CD274 and osteosarcoma: In addition, arginine supplementation stimulates cytotoxicity and effector cytokine production in T and NK cells in vitro and, when combined with anti-PD-L1 treatment, significantly enhances antitumor activity and prolongs survival in osteosarcoma [35].